SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-005511
Filing Date
2023-03-01
Accepted
2023-03-01 16:04:43
Documents
15
Period of Report
2023-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dna-20230301.htm   iXBRL 8-K 66952
2 EX-99.1 dna-ex99_1.htm EX-99 818338
3 GRAPHIC img197909486_0.jpg GRAPHIC 4122
  Complete submission text file 0000950170-23-005511.txt   1089338

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20230301_lab.xml EX-101.LAB 24116
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20230301.xsd EX-101.SCH 3381
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20230301_def.xml EX-101.DEF 15076
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20230301_pre.xml EX-101.PRE 15316
9 EXTRACTED XBRL INSTANCE DOCUMENT dna-20230301_htm.xml XML 6376
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 23693393
SIC: 2836 Biological Products, (No Diagnostic Substances)